Bharat Parenterals Limited (BPLPHARMA.BO)
INR 1060.1
(3.17%)
INR 1060.1
(3.17%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.59 Billion INR | 19.01% |
| 2022 | 2.17 Billion INR | 2.81% |
| 2021 | 2.12 Billion INR | 3.6% |
| 2020 | 2.04 Billion INR | -10.31% |
| 2019 | 2.28 Billion INR | 3.93% |
| 2018 | 2.19 Billion INR | 60.75% |
| 2017 | 1.36 Billion INR | 22.55% |
| 2016 | 1.11 Billion INR | -6.93% |
| 2015 | 1.19 Billion INR | 0.84% |
| 2014 | 1.18 Billion INR | 4.46% |
| 2013 | 1.13 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 925.1 Million INR | 36.41% |
| 2024 Q2 | 716.3 Million INR | -22.57% |
| 2023 Q2 | 598 Million INR | -14.46% |
| 2023 FY | 2.57 Billion INR | 18.07% |
| 2023 Q4 | 678.2 Million INR | 13.37% |
| 2023 Q1 | 699.1 Million INR | 37.16% |
| 2023 Q3 | 598.2 Million INR | 0.03% |
| 2022 Q2 | 819 Million INR | 213.91% |
| 2022 FY | 2.17 Billion INR | 2.81% |
| 2022 Q4 | 509.7 Million INR | -13.64% |
| 2022 Q3 | 590.2 Million INR | -27.94% |
| 2022 Q1 | 260.89 Million INR | -50.12% |
| 2021 FY | 2.12 Billion INR | 3.6% |
| 2021 Q1 | 608.4 Million INR | 49.78% |
| 2021 Q3 | 384.6 Million INR | -36.32% |
| 2021 Q4 | 523.1 Million INR | 36.01% |
| 2021 Q2 | 604 Million INR | -0.72% |
| 2020 Q4 | 406.2 Million INR | -18.02% |
| 2020 FY | 2.04 Billion INR | -10.31% |
| 2020 Q3 | 495.5 Million INR | -16.82% |
| 2020 Q2 | 595.7 Million INR | 8.49% |
| 2020 Q1 | 549.1 Million INR | -7.54% |
| 2019 Q1 | 496.1 Million INR | 4.41% |
| 2019 Q2 | 497.8 Million INR | 0.34% |
| 2019 Q4 | 593.9 Million INR | -19.76% |
| 2019 FY | 2.28 Billion INR | 3.93% |
| 2019 Q3 | 740.2 Million INR | 48.69% |
| 2018 Q3 | 895.3 Million INR | 76.73% |
| 2018 FY | 2.19 Billion INR | 60.75% |
| 2018 Q4 | 475.14 Million INR | -46.93% |
| 2018 Q2 | 506.6 Million INR | 36.26% |
| 2018 Q1 | 371.8 Million INR | -7.47% |
| 2017 FY | 1.36 Billion INR | 22.55% |
| 2017 Q1 | 271.13 Million INR | -18.21% |
| 2017 Q2 | 370.33 Million INR | 36.59% |
| 2017 Q3 | 322.46 Million INR | -12.93% |
| 2017 Q4 | 401.83 Million INR | 24.61% |
| 2016 Q2 | 273.84 Million INR | 15.05% |
| 2016 Q1 | 238.02 Million INR | -38.78% |
| 2016 FY | 1.11 Billion INR | -6.93% |
| 2016 Q4 | 331.48 Million INR | 22.29% |
| 2016 Q3 | 271.06 Million INR | -1.01% |
| 2015 Q4 | 388.79 Million INR | 57.94% |
| 2015 Q3 | 246.16 Million INR | -17.53% |
| 2015 Q1 | 263.91 Million INR | 0.0% |
| 2015 Q2 | 298.49 Million INR | 13.1% |
| 2015 FY | 1.19 Billion INR | 0.84% |
| 2014 FY | 1.18 Billion INR | 4.46% |
| 2013 FY | 1.13 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Add-Shop E-Retail Limited | 2.02 Billion INR | -28.366% |
| Cian Healthcare Limited | 616.95 Million INR | -320.466% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -14012.115% |
| Colinz Laboratories Limited | 70.29 Million INR | -3590.237% |
| Denis Chem Lab Limited | 1.67 Billion INR | -54.574% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -46623.505% |
| Evoq Remedies Limited | 63.09 Million INR | -4011.728% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | -52.754% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | -82.725% |
| MedPlus Health Services Limited | 56.24 Billion INR | 95.388% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -554.377% |
| PANJON LTD. | 125.52 Million INR | -1966.657% |
| PRAVEG LIMITED | 915.96 Million INR | -183.208% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | -383.186% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 80.871% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -231929.428% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -548.151% |
| BDH Industries Limited | 858.31 Million INR | -202.232% |
| DECIPHER LABS LIMITED | 362.75 Million INR | -615.112% |
| ANG Lifesciences India Limited | 1.46 Billion INR | -77.544% |
| Veerhealth Care Limited | 142.13 Million INR | -1725.101% |
| Zenith Healthcare Limited | 144.71 Million INR | -1692.525% |
| Zenlabs Ethica Limited | 585.63 Million INR | -342.956% |
| Zenotech Laboratories Limited | 368.08 Million INR | -604.745% |
| Crestchem Limited | 212.56 Million INR | -1120.392% |
| Norris Medicines Limited | 56.35 Million INR | -4503.029% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | -247.859% |
| Sunil Healthcare Limited | 901.91 Million INR | -187.619% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | -48.804% |
| Bacil Pharma Limited | - INR | -Infinity% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 25.491% |
| Patidar Buildcon Limited | 2.3 Million INR | -112295.537% |
| Phaarmasia Limited | 305.93 Million INR | -747.927% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | -106.051% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 44.038% |
| Trimurthi Limited | 42.23 Million INR | -6041.6% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -2421.52% |
| Vivanza Biosciences Limited | 278.89 Million INR | -830.141% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -24630.257% |
| Anuh Pharma Limited | 6.47 Billion INR | 59.906% |
| Beryl Drugs Limited | 271.24 Million INR | -856.357% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -481.516% |
| Deccan Health Care Limited | 597.28 Million INR | -334.311% |
| Godavari Drugs Limited | 1.56 Billion INR | -65.532% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | -440.72% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -1608.031% |
| Kerala Ayurveda Limited | 1.02 Billion INR | -153.487% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | -147.347% |
| Lactose (India) Limited | 1.13 Billion INR | -127.772% |
| Makers Laboratories Limited | 1.03 Billion INR | -150.001% |
| Medi-Caps Limited | 265.63 Million INR | -876.561% |
| Mercury Laboratories Limited | 755.59 Million INR | -243.32% |
| Parmax Pharma Limited | 154.24 Million INR | -1581.815% |
| Roopa Industries Limited | 715.53 Million INR | -262.537% |
| Smruthi Organics Limited | 1.27 Billion INR | -103.23% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -850.327% |
| Syschem (India) Limited | 2.33 Billion INR | -11.08% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | -106.847% |
| Trident Lifeline Limited | 446.28 Million INR | -481.262% |
| Concord Drugs Limited | 449.24 Million INR | -477.433% |
| Gennex Laboratories Limited | 867.14 Million INR | -199.153% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -600.757% |
| Parnax Lab Limited | 1.88 Billion INR | -37.463% |
| Trinity League India Limited | 2.95 Million INR | -87835.22% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | -285.562% |
| Tyche Industries Limited | 696.83 Million INR | -272.266% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 15.549% |
| Transchem Limited | 4.09 Million INR | -63170.479% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -1616.564% |
| Panchsheel Organics Limited | 1.05 Billion INR | -146.543% |
| Coral Laboratories Limited | 836.6 Million INR | -210.074% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | -66.908% |
| Auro Laboratories Limited | 526.99 Million INR | -392.241% |